Tag Archives: Pharmaceutical

‘Generic’ Biologic Drugs Appear Comparable to Brand-Name Counterparts

NEW ANALYSIS SUGGESTS COMMON AND COSTLY MEDICATIONS MADE FROM LIVING CELLS CAN BE EQUIVALENT EVEN WHEN MANUFACTURED BY DIFFERENT COMPANY Generic forms of a biologic drug used to treat rheumatoid arthritis, inflammatory bowel disease and psoriasis appear to be as safe and effective as their brand-name counterparts, a new Johns Hopkins Bloomberg School of Public Health analysis suggests. Biologics, or ...

Read More »